SanBio Company Limited
SNBIF · OTC
10/31/2025 | 7/31/2025 | 4/30/2025 | 1/31/2025 | |
|---|---|---|---|---|
| Market Cap | $1,184,857 | $155,013,778 | $67,130,687 | $50,330,124 |
| - Cash | $12,371 | $2,738,369 | $3,586,412 | $2,921,000 |
| + Debt | $8,423 | $1,356,500 | $1,415,400 | $397,000 |
| Enterprise Value | $1,180,909 | $153,631,909 | $64,959,675 | $47,806,124 |
| Revenue | $0 | $0 | $0 | $0 |
| % Growth | – | – | – | – |
| Gross Profit | -$13 | -$13 | $0 | $0 |
| % Margin | – | – | – | – |
| EBITDA | -$4,325 | -$879,153 | -$1,005,005 | -$1,030,813 |
| % Margin | – | – | – | – |
| Net Income | -$4,652 | -$465,510 | -$1,531,490 | -$729,631 |
| % Margin | – | – | – | – |
| EPS Diluted | -0.065 | -6.46 | -21.38 | -10.46 |
| % Growth | 99% | 69.8% | -104.4% | – |
| Operating Cash Flow | – | $0 | $0 | $0 |
| Capital Expenditures | – | $0 | $0 | $0 |
| Free Cash Flow | – | $0 | $0 | $0 |